SCHEMBL6022585

SCHEMBL6022585

CCCC(C)Oc1cc(/C=C/C(=O)NCc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)cc(OC(C)CCC)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.40
MAOA P21397 8/20 0.40
MAOB P27338 8/20 0.40
ACHE P22303 6/20 0.39
BCHE P06276 1/20 0.39
GABBR2 O75899 1/20 0.39
GABBR1 Q9UBS5 1/20 0.39
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
HTR1A P08908 2/20 0.37
HTR2C P28335 2/20 0.37
HTR2A P28223 1/20 0.37
SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6022586 1.00 ALOX5 (0.40) ALOX5MAOAMAOBACHEBCHE
SCHEMBL6023523 0.90 ALOX5 (0.50) ALOX5MAOAMAOBACHEBCHE
SCHEMBL6023519 0.90 ALOX5 (0.50) ALOX5MAOAMAOBACHEBCHE
SCHEMBL6022666 0.89 GAA (0.53) ALOX5MAOAMAOBACHEBCHE
SCHEMBL6022660 0.89 GAA (0.53) ALOX5MAOAMAOBACHEBCHE
SCHEMBL6022988 0.88 GAA (0.49) ALOX5MAOAMAOBACHEBCHE
SCHEMBL6022991 0.88 GAA (0.49) ALOX5MAOAMAOBACHEBCHE
SCHEMBL6022819 0.87 ALOX5 (0.42) ALOX5MAOAMAOBACHEBCHE
SCHEMBL6022818 0.87 ALOX5 (0.42) ALOX5MAOAMAOBACHEBCHE
SCHEMBL6022739 0.83 ALOX5 (0.57) ALOX5MAOAMAOBACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US claimed
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 ALOX5 1193/4885MAOA 1480/4885MAOB 2407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.